On the evening of February 20th, 2023, China Health announced the winning rate: the number of shares issued this time was 600 10/0,000 shares. After the callback mechanism was launched, the final number of shares issued offline was about 36,665,438+0,000, accounting for 665,438+0% of the number of shares issued this time.
The final number of online issuance is about 23.4 million shares, accounting for 39% of the number of this issuance. After the callback, the winning rate of this online issuance is 0.028277864%, and the effective subscription multiple is about 3536.34 times.
1 By June, 2022, the income composition of health business in China was: retail-Chinese and western medicines accounted for 56.32%, agency-Chinese and western medicines accounted for 19.2 1%, centralized terminal procurement-Chinese and western medicines accounted for 6. 16%, and retail-medical devices accounted for 4.88%.
Business scope of China Health:
It is an eight-in-one, scientifically distributed pharmaceutical eco-enterprise with Guo Sheng Pharmacy as the pharmaceutical retail platform, Huida Pharmaceutical as the supply chain integration platform, business school as the management output platform, Zhu Jie Science and Technology as the information platform, Yao Zheng Science and Technology as the pharmaceutical R&D and innovation platform, Guo Sheng Medical as the medical health service platform and Keanshu Medicine as the medical device platform.
At present, China is developing healthily and rapidly, with more than 6,000 employees, an output value of nearly 4 billion, and an annual tax payment of 65.438+0.5 billion yuan. In the future, we will continue to ride the wind and waves, practice the business philosophy of "* * * to create, * * * to enjoy and * * * to win", become a comprehensive ecological enterprise covering the medical and health industry, and contribute to the construction of a healthy China in the new era.
Baidu Encyclopedia-Anhui Chinese Health Medicine Co., Ltd.